Tiazesim

Tiazesim
Clinical data
Trade namesAltinil
Other namesThiazesim; Thiazenone; SQ-10496
Routes of
administration		By mouth
ATC code
  • None
Legal status
Legal status
  • In general: ℞ (Prescription only)
Identifiers
  • 5-[2-(dimethylamino)ethyl]-2-phenyl-2,3-dihydro-1,5-benzothiazepin-4(5H)-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC19H22N2OS
Molar mass326.46 g·mol−1
3D model (JSmol)
  • CN(C)CCN1C(=O)CC(SC2=CC=CC=C21)C3=CC=CC=C3
  • InChI=1S/C19H22N2OS/c1-20(2)12-13-21-16-10-6-7-11-17(16)23-18(14-19(21)22)15-8-4-3-5-9-15/h3-11,18H,12-14H2,1-2H3
  • Key:QJJXOEFWXSQISU-UHFFFAOYSA-N

Tiazesim (INNTooltip International Nonproprietary Name), or thiazesim (BANTooltip British Approved Name, USANTooltip United States Adopted Name), previously sold under the brand name Altinil, is a heterocyclic antidepressant related to the tricyclic antidepressants (TCAs) which, introduced in 1966 by Squibb Corporation (now Bristol-Myers Squibb), has since been discontinued and is no longer marketed.[1][2]

See also

References

  1. ^ Ganellin CR, Triggle DJ, Macdonald F (1997). Dictionary of pharmacological agents. CRC Press. p. 1973. ISBN 978-0-412-46630-4. Retrieved 29 November 2011.
  2. ^ The United States patents quarterly. 1969. OCLC 1768767. Retrieved 1 May 2012.



Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.